Community Paramedicine at Home (CP@Home)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02835989|
Recruitment Status : Recruiting
First Posted : July 18, 2016
Last Update Posted : October 25, 2019
|Condition or disease||Intervention/treatment||Phase|
|Cardiovascular Disease Diabetes Mellitus Accidental Falls Social Isolation Food Insecurity||Other: CP@Home||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||261 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Community Paramedicine at Home (CP @Home)|
|Actual Study Start Date :||October 25, 2018|
|Estimated Primary Completion Date :||September 2020|
|Estimated Study Completion Date :||September 2021|
Experimental: CP@Home Intervention
The experimental group will receive the CP@Home program. The main elements of this program include BP assessment, diabetes risk assessment, falls risk assessment, heart failure risk assessment, neurologic assessment, psychiatric assessment, depression screening, health-related quality of life analysis (including pain, mobility, anxiety/depression, ADLs), social isolation screening, and food and income security. The program is targeted at referrals to appropriate community resources, identification and referral of high-risk patients to their family physician (FP), as well as regular communication of participants' health information to their physician.
The intervention will be implemented by community paramedics from the local paramedic service who have undergone a structured training program (4 hours of online, interactive training modules, including case studies and the observation of an intervention visits led by another paramedic) to assure intervention fidelity.
Community paramedics (CPs) will be assigned to visiting the participants for a first time the week following the initial EMS call. Participants will complete the informed consent process with a CP on their first visit. This visit will also include a full assessment and risk analysis that will take approximately 90 minutes and will be located in the participant's home. As a result of the initial visit, the CP will make all relevant clinical referrals and decisions based on predetermined @Home algorithms. A second visit will be made to the participant 2-4 weeks following the initial call for a streamlined follow-up and reassessment during a 30 minute period. A final visit will be made 6-8 weeks following the initial call for a final evaluation of their situation. It is anticipated the patient will be discharged from the CP@Home program at this point. If the patient calls EMS following the third visit, if they meet the inclusion criteria, they will be re-entered into the CP@Home program.
No Intervention: Control
- Change in number of repeat EMS calls [ Time Frame: Baseline and 1 year ]Individual-level change in EMS call rate resulting in ambulance dispatch (pre-post intervention)
- Change in number of ED presentations [ Time Frame: Baseline and 1 year ]Individual-level change in number of ED presentations (pre-post)
- Change in number of hospital admissions [ Time Frame: Baseline and 1 year ]Individual-level change in number of hospital admissions (pre-post)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02835989
|Contact: Francine Marzanek, BSc BEd||9055259140 ext email@example.com|
|Hamilton, Ontario, Canada, L8S4K1|
|Contact: Francine Marzanek 9055259140 firstname.lastname@example.org|
|Principal Investigator:||Gina Agarwal, MBBS MRCGP CCFP PhD||McMaster University|